Invest in JNJ and Hold Apple for a Stress-Free Retirement Growth Strategy

Investors are advised to consider a balanced retirement portfolio, incorporating both defensive stocks like Johnson & Johnson (JNJ) and growth stocks such as Apple Inc. (AAPL). JNJ reported a 4.6% increase in operational sales for Q2 2025, despite losing exclusivity on its drug STELARA, and maintains a strong balance sheet with $19 billion in cash and a 39.3% debt-to-capitalization ratio. The company generated $6 billion in free cash flow in the same quarter, supporting strategies for mergers, acquisitions, and shareholder returns.

Meanwhile, AAPL’s fiscal Q3 2025 results showcased a 13% boost in iPhone sales and a 15% increase in Mac sales, driven by customer loyalty and innovation, with its total devices in use reaching record levels. Apple trades at a trailing P/E of 30.31x, higher than the industry average of 28.38x. JNJ, with a trailing P/E of 17.15x, is considered undervalued against its industry average of 22.26x, making it an attractive investment opportunity for new investors compared to AAPL, which is deemed relatively expensive at its current levels.